Tissue Engineering

Gene Therapy and tissue engineering

Problems and limitations

• 2003, the FDA placed a temporary halt on all gene therapy trials using retroviral vectors in blood stem cells
• 2 children in gene therapy trial developed a leukemia-like condition
• After successful treatment by gene therapy for X-linked severe combined immunodeficiency disease (X-SCID) (bubble baby syndrome)